JGC
ZYNE

J. Goldman & Co’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

J. Goldman & Co’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-41,500
Closed -$704K – 309
2017
Q2 		$704K Sell
41,500
-11,000
-21% -$187K 0.04% 137
2017
Q1 		$1.06M Sell
52,500
-18,900
-26% -$380K 0.05% 143
2016
Q4 		$1.11M Buy
+71,400
New +$1.11M 0.07% 129